RPSG Ventures Acquires Clarionix Healthcare; Launches Scheme Merging WMHL and Transferring Hospital Business
RPSG Ventures Limited announced two major corporate actions: the acquisition of 100% equity in Clarionix Healthcare Private Limited, establishing a new subsidiary focused on medical services, and the launch of a composite scheme involving Woodlands Multispeciality Hospital Limited (WMHL) aimed at integrating hospital operations into the company structure.The Board of Directors approved the details of the strategic acquisitions and arrangements, which are subject to receiving necessary approvals from regulatory authorities including the National Company Law Tribunal (NCLT) and relevant stock exchanges.
Acquisition of Clarionix Healthcare Private Limited
RPSG Ventures completed the acquisition of 100% equity shareholding in Clarionix Healthcare Private Limited ("RPSG WOS"), effective immediately, making it a wholly-owned subsidiary of the company. RPSG acquired the entity to explore new business opportunities within the medical sector.The acquisition details are as follows:
| Particulars | Details |
|---|---|
| Target Entity Name | Clarionix Healthcare Private Limited (RPSG WOS) |
| Acquired Shareholding | 10,000 equity shares representing 100% of the Equity Share Capital |
| Purchase Consideration | INR 1 lakh |
| RPSG WOS Industry Focus | Medical care and nursing homes |
Composite Scheme of Arrangement
A composite scheme of arrangement has been approved involving The Company (RPSG Ventures Limited), WMHL, and RPSG WOS. The Scheme outlines the amalgamation of WMHL with The Company and the transfer and vesting of the Hospital & Nursing Undertaking from The Company into RPSG WOS on a slump sale basis.The proposed transactions are designed to achieve several strategic objectives, including consolidating the hospital and nursing business under a listed platform and enabling enhanced access to capital for long-term growth. Segregating this undertaking into RPSG WOS allows for focused management, dedicated resource allocation, and ring-fencing of risk within the overall corporate structure.
The details related to the amalgamation and slump sale are summarized below:
| Entity | Total Assets (As on March 31, 2026) | Net Worth (As on March 31, 2026) | Revenue from Operations (FY 2025-26) |
|---|---|---|---|
| Woodlands Multispeciality Hospital Limited (WMHL) | INR 458.15 Crore | INR 326.97 Crore | INR 250.08 Crore |
| RPSG Ventures Limited (The Company) | INR 4,336.61 Crore | INR 1,610.86 Crore | INR 270.50 Crore |
Slump Sale of Hospital & Nursing Undertaking
In connection with the Scheme, RPSG WOS will acquire the Hospital & Nursing Undertaking from The Company on a slump sale basis.| Particulars | Details |
|---|---|
| Acquisition Price (Lumpsum) | INR 400,00,00,000 (Rupees Four Hundred Crore only) |
| Buyer | RPSG WOS |
| Seller | The Company |
Shareholding Pattern Details
The Scheme is anticipated to result in changes to the company's shareholding structure. The pre-Scheme and post-Scheme shareholding patterns are as follows:Pre-Scheme Shareholding (As on March 31, 2026)
| Basis of Shareholding | No of Shares | % Holding |
|---|---|---|
| Promoters | 2,10,13,125 | 63.51% |
| Non-Promoters | 1,20,73,284 | 36.49% |
| Total | 3,30,86,409 | 100% |
In the event that all Optionally Convertible Redeemable Preference Shares (OCRPS) issued pursuant to the Scheme are converted into equity shares, the post-Scheme shareholding pattern is projected as follows:
| Basis of Shareholding | No of Shares | % Holding |
|---|---|---|
| Promoters | 35,004,500 | 68.91% |
| Non-Promoters | 15,795,409 | 31.09% |
| Total | 50,799,909 | 100% |
RPSGVENT Stock Price Movement
On Thursday, shares of RPSG VENTURES LIMITED edged higher to close at ₹889.75 after the equity gained 3.71% in trading. The stock experienced a steady session within its intraday range, moving between a low of ₹858.15 and an all-time high mark of ₹900.75.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.